In breast cancer model it has been shown that HIF-1α as a regulator of CD44 that increased the number of CD44 molecules and the percentage of (variant exons v6 and v7/8) CD44 positive cells is higher in cancer cells in hypoxia41, which might also be true for RCC that is known to harbor VHL mutations. Here, CD44 is linked to renal cell carcinoma.